Bolt Biotherapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold BOLT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$184664
Total value held
Flat
2 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Pfizer Inc | $133832 | 31305 | — | Held |
| 2 | Blackrock, Inc. | $37388 | 9711 | — | Held |
| 3 | Morgan Stanley | $12108 | 3145 | -44 | -1.38% |
| 4 | Ubs Group Ag | $982 | 255 | +255 | NEW BUY |
| 5 | Jpmorgan Chase & Co | $165 | 42 | — | Held |
| 6 | Citigroup Inc | $158 | 41 | -215 | -83.98% |
| 7 | Barclays Plc | $23 | 6 | — | Held |
| 8 | Amalgamated Financial Corp. | $8 | 2755 | +2755 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.